Positron Emissions Tomography (PET) Radiopharmaceuticals
Closed Solicitation Posted
- Solicitation number
- W81K0225QA106
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Place of performance
- Washington 98431, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command is seeking to procure Positron Emissions Tomography (PET) Radiopharmaceuticals through solicitation W81K0225QA106. This procurement falls under the Pharmaceutical Preparation Manufacturing NAICS category (325412) and requires specialized medical radiopharmaceuticals used in PET imaging procedures. Offerors must demonstrate their corporate experience and capabilities by completing a mandatory Corporate Experience Data Sheet that documents previous contract performance, customer details, performance periods, and work narratives. The evaluation will focus on vendors' technical and operational qualifications based on their documented past performance in supporting similar contracts or projects. The solicitation has an extremely tight timeline, with quotes due on September 12, 2025, providing contractors only two days to prepare and submit their responses after the September 10, 2025 posting date.
This opportunity does not utilize any set-aside designations and is open to all qualified contractors. No information about potential incumbents, current contractors, award values, or budget ranges is available from the provided documentation. The contract performance location is specified as Tacoma, Washington 98431, indicating the radiopharmaceuticals will likely support medical facilities in the Pacific Northwest region. Specific quantities of radiopharmaceuticals or service timelines are not detailed in the available materials, as the primary RFQ document content was not accessible. The procurement appears to be for ongoing medical supply needs given the specialized nature of PET radiopharmaceuticals, which typically have short shelf lives and require regular replenishment for continuous medical imaging operations.
Notice text
See attached request for quote (RFQ).
Files
| File | Type | Posted |
|---|---|---|
| W81K0225QA106_RFQ_PET Radiopharmaceuticals.pdf | ||
| Attachment 0001_Corporate Experience Data Sheet_MUST BE INCLUDED WITH QUOTE.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside | |
| 6505--Sources Sought Notice - Ga68 Dotatate (NETSPOT) | Veterans Integrated Service Network 17 | No set-aside | |
| 6505--VA Long Beach Pylarify | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity